Utilising peptides derived from healthy human gut microbiome, this technology offers potential therapeutic applications in treating disorders related to mood, behaviour, and gastrointestinal function by modulating the gut-brain axis.
Technology Sectors & Industries
Pharmaceuticals
Filter
Dr Andre Brown
Dr David Riglar
Ryhan Miah
Ryhan is a Junior Officer for Commercialisation at Imperial’s Faculty of Natural Sciences.
Long-lasting nanoparticles for controlled release drug delivery
A nanoparticle drug platform that can deliver small molecule drugs over a sustained period in a stable, low-toxic manner.
Dr Nazila Kamaly
Use of Capsaicin/TRPV1 agonists for prevention of diabetic foot ulcers
Topical use of Capsaicin or TRPV 1 agonists for the prevention of diabetic ulcers in a patient suffering from diabetic peripheral neuropathy (DPN).
Diana Yin
Diana supports and leads on the commercialisation of MedTech, and HealthTech related technologies from Imperial’s Faculty of Engineering
Dr Amritha Nair
Dr Amritha Nair is an Industry Partnerships and Commercialisation Senior Executive in the Faculty of Medicine at Imperial College London. Amritha works across the entire innovation lifecycle from assessment, protection, and management of Intellectual property;...
Catch up: Innovations in engineering with AI and machine learning
This event highlighted some of the AI, machine learning and data-driven technologies from across Imperial that are being used for applications ranging from wireless video transfer to electric vehicle charging infrastructure, planning new offshore windfarms and optimising drug development and production.
Sign up for updates
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean nec venenatis arcu. In fermentum non tellus nec vulputate. Integer accumsan, nunc sit amet porta commodo, diam sapien feugiat purus, at imperdiet arcu nisi quis dui. Etiam vel nisl sem. Proin felis nisl, fringilla eu eros ac, sodales pellentesque sem.